Clinical Trials Browser

Withdrawn × Interventional × Thyroid Neoplasms × Clear all

NCT04731740 2024-03-25

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Phase 2 Withdrawn

Thyroid Neoplasms

NCT04868045 2023-02-21

Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

Phase 1 Withdrawn

Thyroid Neoplasms

NCT04224792 2022-06-09

Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors

Phase NA Withdrawn

Thyroid Neoplasms

NCT01707056 2021-02-17

The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma

Phase NA Withdrawn

Hypothyroidism, Thyroid Neoplasms

NCT02390739 2019-12-16

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Phase 1/2 Withdrawn

Neoplasm Metastasis, Thyroid Neoplasms

NCT01747512 2017-11-14

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

Phase 2 Withdrawn

Head and Neck Neoplasms, Thyroid Neoplasms

NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

NCT01994200 2016-02-23

ITCA-ThyCa

Phase 1/2 Withdrawn

Thyroid Neoplasms

NCT01701349 2014-05-01

FACT2

Phase 3 Withdrawn

EndocrineHead & Neck

Head and Neck Neoplasms, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT00954837 2013-05-27

CYT2THYR

Phase NA Withdrawn

Thyroid Neoplasms